BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9278049)

  • 1. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E.
    Barger SW; Harmon AD
    Nature; 1997 Aug; 388(6645):878-81. PubMed ID: 9278049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.
    Furukawa K; Sopher BL; Rydel RE; Begley JG; Pham DG; Martin GM; Fox M; Mattson MP
    J Neurochem; 1996 Nov; 67(5):1882-96. PubMed ID: 8863493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function.
    Barger SW; Basile AS
    J Neurochem; 2001 Feb; 76(3):846-54. PubMed ID: 11158256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.
    Combs CK; Karlo JC; Kao SC; Landreth GE
    J Neurosci; 2001 Feb; 21(4):1179-88. PubMed ID: 11160388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Astrocytes down-regulate neuronal beta-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner.
    Vincent B; Smith JD
    Eur J Neurosci; 2001 Jul; 14(2):256-66. PubMed ID: 11553277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients.
    Olsson A; Höglund K; Sjögren M; Andreasen N; Minthon L; Lannfelt L; Buerger K; Möller HJ; Hampel H; Davidsson P; Blennow K
    Exp Neurol; 2003 Sep; 183(1):74-80. PubMed ID: 12957490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity.
    Ikezu T; Luo X; Weber GA; Zhao J; McCabe L; Buescher JL; Ghorpade A; Zheng J; Xiong H
    J Neurochem; 2003 May; 85(4):925-34. PubMed ID: 12716424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of apolipoprotein E inhibits aggregation of the C-terminal fragments of beta-amyloid precursor protein.
    Ohman T; Dang N; LeBoeuf RC; Furlong CE; Fukuchi K
    Neurosci Lett; 1996 May; 210(1):65-8. PubMed ID: 8762193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue.
    Martins RN; Taddei K; Kendall C; Evin G; Bates KA; Harvey AR
    Neuroscience; 2001; 106(3):557-69. PubMed ID: 11591456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C -activating isophthalate derivatives mitigate Alzheimer's disease-related cellular alterations.
    Sarajärvi T; Jäntti M; Paldanius KMA; Natunen T; Wu JC; Mäkinen P; Tarvainen I; Tuominen RK; Talman V; Hiltunen M
    Neuropharmacology; 2018 Oct; 141():76-88. PubMed ID: 30138694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins.
    Lahiri DK; Utsuki T; Chen D; Farlow MR; Shoaib M; Ingram DK; Greig NH
    Ann N Y Acad Sci; 2002 Jun; 965():364-72. PubMed ID: 12105112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein.
    Fuller SJ; Storey E; Li QX; Smith AI; Beyreuther K; Masters CL
    Biochemistry; 1995 Jun; 34(25):8091-8. PubMed ID: 7794922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept.
    Maezawa I; Nguyen HM; Di Lucente J; Jenkins DP; Singh V; Hilt S; Kim K; Rangaraju S; Levey AI; Wulff H; Jin LW
    Brain; 2018 Feb; 141(2):596-612. PubMed ID: 29272333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40.
    Qin S; Colin C; Hinners I; Gervais A; Cheret C; Mallat M
    J Neurosci; 2006 Mar; 26(12):3345-56. PubMed ID: 16554485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease.
    Mattson MP; Barger SW; Furukawa K; Bruce AJ; Wyss-Coray T; Mark RJ; Mucke L
    Brain Res Brain Res Rev; 1997 Feb; 23(1-2):47-61. PubMed ID: 9063586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives.
    Mattson MP
    Physiol Rev; 1997 Oct; 77(4):1081-132. PubMed ID: 9354812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of APP and APLP2 mRNA in APOE genotyped Alzheimer's disease brains.
    Johnston JA; Norgren S; Ravid R; Wasco W; Winblad B; Lannfelt L; Cowburn RF
    Brain Res Mol Brain Res; 1996 Dec; 43(1-2):85-95. PubMed ID: 9037522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term interleukin-1(beta) increases the release of secreted APP(alpha) via MEK1/2-dependent and JNK-dependent alpha-secretase cleavage in neuroglioma U251 cells.
    Ma G; Chen S; Wang X; Ba M; Yang H; Lu G
    J Neurosci Res; 2005 Jun; 80(5):683-92. PubMed ID: 15880353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.